INSMED INC - NOTE 0.750% 6/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q2 2025

Type / Class
Debt / NOTE 0.750% 6/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INSMED INC - NOTE 0.750% 6/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q2 $0 $0 -$1,270,125,799 0
2025 Q1 $539,267,199 $1,279,061,991 -$701,078 237.05% 46
2024 Q4 $543,155,430 $1,179,272,492 -$17,798,757 216.92% 46
2024 Q3 $550,238,034 $1,265,370,683 +$16,403,988 229.55% 51
2024 Q2 $553,273,339 $1,168,729,790 +$103,955,230 211.13% 64
2024 Q1 $570,490,328 $612,063,448 -$5,922,167 107.35% 66
2023 Q4 $558,902,290 $641,198,515 -$7,370,827 114.55% 58
2023 Q3 $569,967,523 $572,136,156 -$8,834,737 99.39% 59
2023 Q2 $585,856,164 $494,822,991 +$1,884,849 84.37% 59
2023 Q1 $606,457,948 $471,666,065 -$8,083,414 77.68% 58
2022 Q4 $638,488,000 $527,785,345 -$10,613,976 82.51% 54
2022 Q3 $540,885,000 $492,918,335 -$2,546,945 90.7% 43
2022 Q2 $592,407,000 $494,715,040 -$14,948,688 83.47% 46
2022 Q1 $607,932,000 $589,082,808 -$5,529,818 96.9% 45
2021 Q4 $567,849,999 $617,600,382 -$1,641,914 108.53% 46
2021 Q3 $569,746,000 $626,058,000 +$89,643,448 109.81% 44
2021 Q2 $487,047,000 $538,424,000 +$538,424,000 110.6% 36